| Value | ₹143.1 Cr |
|---|
BSE filing, NSE: GSLSU. Summary written from the filing by ALFA Finder's alert engine.
Global Surfaces Ltd: key numbers
- Share price
- ₹24.99
- Market cap
- ₹105.9 Cr
- Revenue (annual)
- ₹233.2 Cr
- Net profit (annual)
- ₹-30.43 Cr
- P/E (TTM)
- -3.5×Sector 33.8×
- Promoter holding
- 73.25%+0.00% QoQ
- FII holding
- 0.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Surfaces Ltd
All →Global Surfaces Board Meeting Date
Global Surfaces Ltd notified BSE and NSE that its Board will meet on 2 November 2026 to approve Q2/H1 FY27 un-audited results. The trading window will reopen 48 hours after results declaration.
Global Surfaces Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Global Surfaces Annual General Meeting
Global Surfaces Ltd held its 35th Annual General Meeting on September 19, 2026, via video conference. Shareholders voted on the company's financial results and director appointments.
Global Surfaces Annual Report
Global Surfaces Ltd has filed its Annual Report for the financial year 2025-26 along with the notice for its 35th Annual General Meeting.
Global Surfaces Annual General Meeting
Global Surfaces Ltd has scheduled its 35th Annual General Meeting for September 19, 2026. The meeting will be held via video conferencing to conduct ordinary and special business.
Global Surfaces Earnings Call Transcript: Key Takeaways
Global Surfaces achieved a turnaround with 44% revenue growth despite US trade disruptions. Management pivoted to domestic markets and premium 'Marqwood' technology to offset high freight and US tariff risks.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.